Pale Fire Capital SE has initiated a new position in Baxter International (NYSE:BAX) by purchasing 2,074,016 shares, valued at approximately $39.63 million, as per its SEC filing on February 13, 2026. Baxter International is a prominent provider of essential healthcare products and services, catering to both acute and chronic care markets. The firm is shifting its portfolio focus towards healthcare stocks, marking Baxter as its largest new addition for the fourth quarter, alongside new investments in Teladoc Health, Fractyl Health, and Syndax Pharmaceuticals.
